Trial intelligence / Profile preview

Postoperative GnRHa versus no drug treatment for recurrence and pregnancy in moderate to severe endometriosis

ChiCTR-TRC-08000068Phase 4Recruiting

Sponsor
Women's Hospital, School of Medicine, Zhejiang University
Start
Mar 2008
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised, open-label trial of goserelin in endometriosis (2 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoint: Recurrence rate. Started Mar 2008; status: recruiting.

02

Drugs

goserelin
03

Conditions

endometriosis

Beyond the preview

Go deeper on ChiCTR-TRC-08000068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call